Cargando…

P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY

Detalles Bibliográficos
Autores principales: Nordberg Nørgaard, Jakob, Falck Moore, Kari Lenita, Slørdahl, Tobias, Vik, Anders, Tvedt, Tor Henrik Anderson, Schjesvold, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431519/
http://dx.doi.org/10.1097/01.HS9.0000970780.55147.2c
_version_ 1785091221384855552
author Nordberg Nørgaard, Jakob
Falck Moore, Kari Lenita
Slørdahl, Tobias
Vik, Anders
Tvedt, Tor Henrik Anderson
Schjesvold, Fredrik
author_facet Nordberg Nørgaard, Jakob
Falck Moore, Kari Lenita
Slørdahl, Tobias
Vik, Anders
Tvedt, Tor Henrik Anderson
Schjesvold, Fredrik
author_sort Nordberg Nørgaard, Jakob
collection PubMed
description
format Online
Article
Text
id pubmed-10431519
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104315192023-08-17 P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY Nordberg Nørgaard, Jakob Falck Moore, Kari Lenita Slørdahl, Tobias Vik, Anders Tvedt, Tor Henrik Anderson Schjesvold, Fredrik Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431519/ http://dx.doi.org/10.1097/01.HS9.0000970780.55147.2c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Nordberg Nørgaard, Jakob
Falck Moore, Kari Lenita
Slørdahl, Tobias
Vik, Anders
Tvedt, Tor Henrik Anderson
Schjesvold, Fredrik
P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY
title P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY
title_full P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY
title_fullStr P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY
title_full_unstemmed P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY
title_short P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY
title_sort p969: vrd outperformed vcd as induction therapy before first-line asct in mulitple myeloma; results from a nationwide, population-based study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431519/
http://dx.doi.org/10.1097/01.HS9.0000970780.55147.2c
work_keys_str_mv AT nordbergnørgaardjakob p969vrdoutperformedvcdasinductiontherapybeforefirstlineasctinmulitplemyelomaresultsfromanationwidepopulationbasedstudy
AT falckmoorekarilenita p969vrdoutperformedvcdasinductiontherapybeforefirstlineasctinmulitplemyelomaresultsfromanationwidepopulationbasedstudy
AT slørdahltobias p969vrdoutperformedvcdasinductiontherapybeforefirstlineasctinmulitplemyelomaresultsfromanationwidepopulationbasedstudy
AT vikanders p969vrdoutperformedvcdasinductiontherapybeforefirstlineasctinmulitplemyelomaresultsfromanationwidepopulationbasedstudy
AT tvedttorhenrikanderson p969vrdoutperformedvcdasinductiontherapybeforefirstlineasctinmulitplemyelomaresultsfromanationwidepopulationbasedstudy
AT schjesvoldfredrik p969vrdoutperformedvcdasinductiontherapybeforefirstlineasctinmulitplemyelomaresultsfromanationwidepopulationbasedstudy